RecruitingPhase 1NCT07310420A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast CancerSponsor: TerSera Therapeutics LLCAmsterdam, NY · New York, NY · The Bronx, NY · +23 more sites
RecruitingPhase 3NCT06492616A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceSponsor: Stemline Therapeutics, Inc.Brooklyn, NY · East Syracuse, NY · Ithaca, NY · +173 more sites
RecruitingPhase 1 / Phase 2NCT06330064A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)Sponsor: Daiichi SankyoNew York, NY · Westbury, NY · +15 more sites